MedImmune to Acquire Amplimmune (Photo)
AstraZeneca has announced that MedImmune, its global biologics research and development arm, has entered into a definitive agreement to acquire Amplimmune, a privately-held biologics company focused on developing novel therapeutics in cancer immunology.The buyout is designed to strengthen MedImmune’s cancer-related research, and includes an initial payment of $225 million, with the possibility of another $275 million if certain development milestones are reached.
“MedImmune’s focus on harnessing the power of the patient’s own immune system to fight cancer will be complemented by Amplimmune’s innovative work in this area. It will allow us to strengthen our arsenal of potential cancer therapies,” said Dr. Bahija Jallal, Executive Vice President of MedImmune. “We are excited to be working with the Amplimmune team to help find new treatments to address areas of unmet medical need.”
“Both companies are passionate about developing new cancer therapies for patients and are excited about the potential of immunotherapies. We are pleased to be joining MedImmune, who will work to further advance the pioneering work we’ve been conducting in this area,” said Michael Richman, Amplimmune’s President and Chief Executive Officer. “The synergy achieved by combining our pipelines provides an important path towards developing novel immunotherapy products.”
Amplimmune has been in the city of Gaithersburg since its move from Rockville in 2011. Gaithersburg officials awarded it a $50,000 toolbox grant to support the renovation of 20,570 square feet of space on West Watkins Mill Road, including interior demolition and the construction of new office space, lab space and manufacturing facilities. At the time of the application Amplimmune employed 23 people.
“These are the kind of success stories we love to hear,” said Tom Lonergan, Gaithersburg’s economic development director. “Our grants are designed to provide the basis for growth and innovation, and Amplimmune serves as an excellent example of that. From lab space fit ups to employee training to signage, Toolbox grants help lay the foundation for future success.”
For more information on the MedImmune acquisition, visit www.medimmune.com/media.
Additional Coverage
Novavax’s Vaccine Candidate Shows Nearly 90% Efficacy in UK
Novavax, a vaccine development company headquartered in Gaithersburg, says its COVID-19 vaccine candidate showed 89.3% efficacy in UK clinical trials. The UK study enrolled more than 15,000 volunteers, according to a statement from Novavax on Thursday. More details will be released as data comes in, the company said. Phase 2b results in South Africa showed […]
AstraZeneca Says its Coronavirus Vaccine Candidate Shows 70% Average Efficacy
AstraZeneca, a multinational pharmaceutical company with a Gaithersburg campus, announced Monday that its COVID-19 vaccine candidate shows a 70% average efficacy rate. The vaccine candidate AZD1222 was administered in two ways. It showed 90% efficacy when it was given as a half dose and followed by a full dose at least one month later, according […]
Delaney's Idea for Stimulus Check: 'Pay Everyone $1500 to Get Vaccine'
Former U.S. Rep. John Delaney (D-Md. 6) is getting attention on Twitter for his idea for distributing a coronavirus vaccine, once it is made available. Delaney tweeted Friday, “Pay everyone $1500 to get vaccine[.] It is a stimulus check & big vaccine incentive rolled into one[.] Result: more people get vaccine, it saves lives, helps […]
Discovery Park Opens in Gaithersburg
Discovery Park officially opened in Gaithersburg, Sept. 25, with a ribbon cutting ceremony featuring city officials. The project cost $1.4 million and was funded by the city’s Capital Improvement Plan. Across the new 15 acre parkland, there are five walking trails and picnic structures, with two being ADA accessible; two playgrounds; a secret garden and […]
MCM's April Small Business Network: Connecting to Corporations (LIVE)
Montgomery Community Media’s April Small Business Network (SBN) session took place April 25 in Rockville. The topic of the session was Connecting to Corporations. Kelly Leonard moderated a panel of three business leaders, including Anna Hakobyan of AstraZeneca, Casey Oakes of Marriott International, and Karen Zuckerman of HZ. The panel discussed: How to make connections […]
New Biotech in Gaithersburg Bringing 100 Jobs
A new biotech company is opening in Gaithersburg, and is bringing with it 100 new jobs in the next three to five years. Viela Bio, a newly formed spin-out of MedImmune, announced Wednesday it will locate in Gaithersburg and plans to create 100 new jobs within three to five years. The company will focus on […]
MedImmune and Johns Hopkins Announce Joint Program to Train Ph.D Students
The Johns Hopkins University and MedImmune announced this week a first-of-its-kind Ph.D. training program between a major university and a biopharmaceutical company in the United States. Known as the Johns Hopkins-MedImmune Scholars Program, this new initiative will build on an ongoing collaboration between MedImmune and Johns Hopkins, and reinforces both partners’ commitment to grow the […]
Five Things to Know Today, Oct. 15, in Montgomery County
Here are your five things to know today, Oct. 15, in Montgomery County: 1. Crews are finishing road repairs at the scene of Tuesday’s water main break at Rockville Pike and Cedar Lane. According to WSSC, all southbound lanes should be open by 8 a.m. today. All northbound lanes are already open. 2. The Maryland […]
Gaithersburg Public Hearing Set for Proposed MedImmune Parking Garage
The Gaithesburg City Council and Planning Commission will hold a joint public hearing at 7:30 p.m. on July 20th to discuss a schematic development plan (SDP) application for construction of a structured parking garage on the MedImmune/Astrazeneca campus. The proposed parking garage would include 1,386 spaces to serve future development on the company’s Gaithersburg campus. […]
MedImmune Alerts Community of Plans to Build Childcare Center
UPDATED MedImmune and AstraZeneca officials are planning to build a child care center adjacent to the company’s corporate campus at One MedImmune Way in Gaithersburg. In an email sent on Feb. 11, the biotech company alerted Quince Orchard Park community residents that a Schematic Development Plan (SDP) application for construction of the child care center […]
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia